Bioorganic and Medicinal Chemistry Letters p. 2467 - 2472 (1998)
Update date:2022-08-05
Topics:
Nerenberg, Jennie B.
Erb, Jill M.
Thompson, Wayne J.
Lee, Hee-Yoon
Guare, James P.
Munson, Peter M.
Bergman, Jeffrey M.
Huff, Joel R.
Broten, Theodore P.
Chang, Raymond S. L.
Chen, Tsing B.
O'Malley, Stacey
Schorn, Terry W.
Scott, Ann L.
Benign prostatic hyperplasia can be managed pharmacologically with α-1 adrenergic receptor antagonists. Agents that demonstrate selectivity for the α-la receptor subtype may offer advantages in clinical applications with respect to hypotensive side effect
View Morewebsite:http://www.antaibio.com
Contact:0086-21-65663057
Address:Room 2108, Building 2，No. 489 Zhengli Road，200433
hangzhou verychem science and technology co.ltd
website:http://www.verypharm.com
Contact:+86-571-88162785; 88162786
Address:F1502, 753 Shenhua road, Hangzhou, China
Shanghai Demand Chemical Co., ltd，China
Contact:86-021-55237578/55239122
Address:Room 3H, No.578, Yingkou Road, Yangpu District, Shanghai, China
Nanyang Tianhua pharmaceutical Co.,Ltd.
Contact:+8618639816203
Address:Longsheng Industrial Park
Tianjin Jiuri New Materials Co., Ltd.
Contact:+86-22-58889220
Address:C-5/6, Vison Hill, No.1 Gonghua Road, Huayuan Hi-tech Park, Tianjin, China.
Doi:10.1021/jo01271a045
(1968)Doi:10.1039/DT9950001857
(1995)Doi:10.1248/cpb.15.1331
(1967)Doi:10.1039/j39670002700
(1967)Doi:10.1016/S0040-4039(00)72432-4
(1973)Doi:10.1016/0957-4166(95)00201-Y
(1995)
